Muscle-invasive Urothelial Cancer of the Bladder
1 clinical trials · Condition
◉ Watch Muscle-invasive Urothelial Cancer of the Bladder
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder (NCT02621151) | NYU Langone Health | 2016-08-11 |
Track Muscle-invasive Urothelial Cancer of the Bladder automatically
Every clearance here is in the API, with alerts when new ones post.